Mannkind Corp SEC filings MNKD
Mannkind Corp has 1,000 filings in SEC EDGAR's recent list, going back to Aug 14, 2013. Its latest annual report, Form ARS, was filed on Apr 7, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SC TO-T/A | Filing | Oct 7, 2025 | — |
| SC TO-T/A | Filing | Sep 30, 2025 | — |
| SC TO-T/A | Filing | Sep 29, 2025 | — |
| SC TO-T/A | Filing | Sep 24, 2025 | — |
| SC TO-T/A | Filing | Sep 22, 2025 | — |
| SC TO-T | Filing | Sep 8, 2025 | — |
| SC TO-C | Filing | Aug 25, 2025 | — |
| SC TO-C | Filing | Aug 25, 2025 | — |
| SC TO-C | Filing | Aug 25, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 24, 2025 | — |
| CORRESP | Letter to the SEC | Jul 18, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 14, 2025 | — |
| CORRESP | Letter to the SEC | Jul 2, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 18, 2025 | — |
| CORRESP | Letter to the SEC | Jun 5, 2025 | — |
| UPLOAD | Letter from the SEC | May 16, 2025 | — |
| CT ORDER | Filing | Oct 29, 2021 | — |
| EFFECT | Filing | Apr 5, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 4, 2019 | — |
| CORRESP | Letter to the SEC | Apr 3, 2019 | — |
| CT ORDER | Filing | Nov 30, 2018 | — |
| CT ORDER | Filing | Jun 13, 2018 | — |
| CT ORDER | Filing | Dec 6, 2017 | — |
| EFFECT | Filing | Jul 14, 2017 | — |
| CORRESP | Letter to the SEC | Jul 12, 2017 | — |
| UPLOAD | Letter from the SEC | Jul 11, 2017 | — |
| CT ORDER | Filing | Apr 26, 2017 | — |
| EFFECT | Filing | Apr 27, 2016 | — |
| CORRESP | Letter to the SEC | Apr 26, 2016 | — |
| UPLOAD | Letter from the SEC | Apr 26, 2016 | — |
| NT 10-K | Form 12b-25 | Mar 1, 2016 | Dec 31, 2015 |
| CT ORDER | Filing | Dec 15, 2014 | — |
| UPLOAD | Letter from the SEC | Dec 5, 2014 | — |
| CORRESP | Letter to the SEC | Nov 4, 2014 | — |
| UPLOAD | Letter from the SEC | Oct 23, 2014 | — |
| POSASR | Filing | Mar 3, 2014 | — |
| POSASR | Filing | Dec 23, 2013 | — |
| POSASR | Post effective amendment no. 1 to form s-3 | Sep 18, 2013 | — |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MNKD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Danbury, CT
- SEC filer status
- Large accelerated filer
- SEC CIK
- 899460
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.